Walker Q - Search Results

1

Breast cancer metastases masquerading as primary gastric carcinoma.

Walker Q, Bilous M, Tiver KW, Langlands AO. Walker Q, et al. Aust N Z J Surg. 1986 May;56(5):395-8. doi: 10.1111/j.1445-2197.1986.tb02338.x. Aust N Z J Surg. 1986. PMID: 3459449

2

The misuse of mammography in the management of breast cancer revisited.

Walker QJ, Gebski V, Langlands AO. Walker QJ, et al. Med J Aust. 1989 Nov 6;151(9):509-12. doi: 10.5694/j.1326-5377.1989.tb128497.x. Med J Aust. 1989. PMID: 2682150

3

The misuse of mammography in the management of breast cancer.

Walker QJ, Langlands AO. Walker QJ, et al. Med J Aust. 1986 Sep 1;145(5):185-7. Med J Aust. 1986. PMID: 3747891

4

The management of oesophageal carcinoma: radiotherapy or surgery? Cost considerations.

Walker QJ, Salkeld G, Hall J, O'Rourke I, Bull CA, Tiver KW, Langlands AO. Walker QJ, et al. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1657-62. doi: 10.1016/0277-5379(89)90314-3. Eur J Cancer Clin Oncol. 1989. PMID: 2512173

5

Rapid progression of a malignant schwannoma.

Walker QJ, Langlands AO. Walker QJ, et al. Australas Radiol. 1985 Aug;29(3):279. doi: 10.1111/j.1440-1673.1985.tb01712.x. Australas Radiol. 1985. PMID: 4074231 No abstract available.

6

Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix.

Ludgate SM, Crandon AJ, Hudson CN, Walker Q, Langlands AO. Ludgate SM, et al. Among authors: walker q. Int J Radiat Oncol Biol Phys. 1988 Oct;15(4):893-9. doi: 10.1016/0360-3016(88)90123-x. Int J Radiat Oncol Biol Phys. 1988. PMID: 3141318

7

Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.

King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.

8

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients.

Ball D, Bishop J, Smith J, Crennan E, O'Brien P, Davis S, Ryan G, Joseph D, Walker Q. Ball D, et al. Among authors: walker q. Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):267-72. doi: 10.1016/0360-3016(94)E0021-B. Int J Radiat Oncol Biol Phys. 1995. PMID: 7836079 Clinical Trial.

9

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial.

Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D. Ball D, et al. Among authors: walker q. Radiother Oncol. 1999 Aug;52(2):129-36. doi: 10.1016/s0167-8140(99)00093-6. Radiother Oncol. 1999. PMID: 10577698 Clinical Trial.

10

Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG).

Denham JW, Burmeister BH, Lamb DS, Spry NA, Joseph DJ, Hamilton CS, Yeoh E, O'Brien P, Walker QJ. Denham JW, et al. Among authors: walker qj. Radiother Oncol. 1996 Jul;40(1):31-43. doi: 10.1016/0167-8140(96)01762-8. Radiother Oncol. 1996. PMID: 8844885 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page